Sofie Van Huffel

1.2k total citations
8 papers, 1.1k citations indexed

About

Sofie Van Huffel is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Sofie Van Huffel has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Sofie Van Huffel's work include NF-κB Signaling Pathways (6 papers), interferon and immune responses (3 papers) and Immune Response and Inflammation (3 papers). Sofie Van Huffel is often cited by papers focused on NF-κB Signaling Pathways (6 papers), interferon and immune responses (3 papers) and Immune Response and Inflammation (3 papers). Sofie Van Huffel collaborates with scholars based in Belgium, United States and France. Sofie Van Huffel's co-authors include Rudi Beyaert, Karen Heyninck, Peter Schotte, Peter Vandenabeele, Sigrid Cornelis, Wim Declercq, Sandrine A. Tinton, Geertrui Denecker, Dirk De Valck and Karim El Bakkouri and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and Hepatology.

In The Last Decade

Sofie Van Huffel

8 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofie Van Huffel Belgium 8 695 366 335 140 105 8 1.1k
Lisa J. Pagliari United States 12 850 1.2× 610 1.7× 260 0.8× 164 1.2× 183 1.7× 13 1.4k
Limin Li China 18 689 1.0× 388 1.1× 448 1.3× 134 1.0× 69 0.7× 32 1.2k
Rama Mohan Surabhi United States 11 879 1.3× 314 0.9× 329 1.0× 157 1.1× 64 0.6× 15 1.2k
Nickolay Neznanov United States 20 807 1.2× 250 0.7× 152 0.5× 255 1.8× 109 1.0× 30 1.3k
John F. DeLamarter Switzerland 19 654 0.9× 539 1.5× 348 1.0× 265 1.9× 78 0.7× 37 1.4k
Preethi Jayanth Canada 18 606 0.9× 332 0.9× 104 0.3× 97 0.7× 113 1.1× 25 920
Kelly Verhelst Belgium 12 582 0.8× 594 1.6× 488 1.5× 183 1.3× 126 1.2× 13 1.1k
Hans‐Hermann Wessels United States 17 1.2k 1.7× 228 0.6× 244 0.7× 112 0.8× 95 0.9× 21 1.6k
Pin Ling Taiwan 19 628 0.9× 270 0.7× 89 0.3× 214 1.5× 151 1.4× 39 1.2k
Sudha Arya Canada 11 775 1.1× 388 1.1× 88 0.3× 185 1.3× 85 0.8× 12 1.2k

Countries citing papers authored by Sofie Van Huffel

Since Specialization
Citations

This map shows the geographic impact of Sofie Van Huffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Van Huffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Van Huffel more than expected).

Fields of papers citing papers by Sofie Van Huffel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Van Huffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Van Huffel. The network helps show where Sofie Van Huffel may publish in the future.

Co-authorship network of co-authors of Sofie Van Huffel

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Van Huffel. A scholar is included among the top collaborators of Sofie Van Huffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Van Huffel. Sofie Van Huffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wullaert, Andy, Lynn Verstrepen, Sofie Van Huffel, et al.. (2006). LIND/ABIN-3 Is a Novel Lipopolysaccharide-inducible Inhibitor of NF-κB Activation. Journal of Biological Chemistry. 282(1). 81–90. 66 indexed citations
2.
Wullaert, Andy, Ben Wielockx, Sofie Van Huffel, et al.. (2005). Adenoviral gene transfer of ABIN‐1 protects mice from TNF/galactosamine‐induced acute liver failure and lethality†. Hepatology. 42(2). 381–389. 44 indexed citations
3.
Heyninck, Karen, Sofie Van Huffel, Marja Kreike, & Rudi Beyaert. (2004). Yeast Two-Hybrid Screening for Proteins Interacting With the Anti-Apoptotic Protein A20. Humana Press eBooks. 282. 223–242. 10 indexed citations
4.
Huffel, Sofie Van, et al.. (2001). Functional redundancy of the zinc fingers of A20 for inhibition of NF‐κB activation and protein–protein interactions. FEBS Letters. 498(1). 93–97. 63 indexed citations
5.
Huffel, Sofie Van, et al.. (2001). Identification of a Novel A20-binding Inhibitor of Nuclear Factor-κB Activation Termed ABIN-2. Journal of Biological Chemistry. 276(32). 30216–30223. 87 indexed citations
6.
Beyaert, Rudi, Karen Heyninck, & Sofie Van Huffel. (2000). A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis. Biochemical Pharmacology. 60(8). 1143–1151. 255 indexed citations
7.
Cornelis, Sigrid, et al.. (2000). Identification and Characterization of a Novel Cell Cycle–Regulated Internal Ribosome Entry Site. Molecular Cell. 5(4). 597–605. 282 indexed citations
8.
Schotte, Peter, Wim Declercq, Sofie Van Huffel, Peter Vandenabeele, & Rudi Beyaert. (1999). Non‐specific effects of methyl ketone peptide inhibitors of caspases. FEBS Letters. 442(1). 117–121. 258 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026